Safety and identifying predictors for sustained treatment and dose escalation of Vedolizumab in clinical practice.
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- 19 Jan 2018 New trial record